MedBeat offers a heart activity monitoring solution that utilizes biosensors and real-time data analytics to provide accurate cardiac health insights. This technology enables healthcare providers to detect arrhythmias and other heart conditions early, enhancing patient outcomes and minimizing the need for emergency interventions.
Funding
$3.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional long-term ECG monitoring often involves long wait times and requires patients to visit a clinic, creating inconvenience and potentially delaying diagnosis. Existing methods may also be less effective at capturing intermittent arrhythmias due to limited monitoring duration.
Solution
MedBeat offers a remote long-term ECG monitoring service, providing a convenient alternative to traditional clinic-based methods. Patients receive a user-friendly, wireless, and water-resistant ECG device directly, enabling them to record their heart activity for up to 7 days in their own environment. The recorded data is then analyzed by MedBeat's specialist physicians, who deliver a comprehensive report within one week, facilitating faster and more reliable diagnoses.
Target Audience
MedBeat primarily serves healthcare providers seeking a remote long-term ECG monitoring solution for their patients, as well as individuals seeking convenient and timely cardiac health assessments.
Features
- Wireless and water-resistant ECG device for easy and comfortable use
- Extended monitoring period of up to 7 days to capture intermittent arrhythmias
- Remote data transmission for analysis by specialist physicians
- Rapid report delivery within one week of completed recording
- Non-invasive and simple to use for patients of all ages